Teladoc Health (TDOC)

Telemedicine appointment
fizkes / Shutterstock

Teladoc Health is one of the leading telemedicine companies in the U.S. It has a consistent track record of revenue growth and margin improvement.

Unsurprisingly, the company benefited from the extraordinary environment brought on by COVID-19. When most forms of non-life-threatening, in-office medical care were put on hold during the peak of the pandemic, telehealth adoption exploded.

Teladoc’s revenue increased 98% in 2020 to $1.09 billion, with total visits surging 156%.

For 2021, management is projecting a top-line of between $2.015 billion and $2.025 billion.

Teladoc is currently the second-largest holding at Ark Innovation ETF, accounting for 6.4% of the fund’s weight.

If you’re not ready to commit big to a few key stocks, you can always build a diversified portfolio using nothing more than digital nickels and dimes.

Join Masterworks to invest in works by Banksy, Picasso, Kaws, and more. Use our special link to skip the waitlist and join an exclusive community of art investors.

Skip waitlist

Zoom Video Communications (ZM)

Zoom app and meetings

One of investors’ favorite stay-at-home stocks, Zoom has gone on a rollercoaster ride.

Shares of the video communications company were trading in the $60s at the beginning of 2020. They skyrocketed to over $560 apiece by October 2020, but have since given up more than half of the gains.

Wood was not afraid to buy the dip. Earlier this month, Ark Invest bought over 225,000 shares of Zoom. Wood’s flagship ETF now owns 3.82 million shares of the company, with a portfolio weighting of 4.95%.

In the most recent fiscal quarter, total revenue rose 35% year-over-year to $1.05 billion. It also brought in $338.4 million in adjusted net income and $374.8 million in free cash flow.

Even after this year’s pullback, Zoom trades at well over $200 per share. But you can still get a piece of the company using a popular app that allows you to buy fractions of shares with as much money as you’re willing to spend.

Roku (ROKU)

Roku TV and products for sale
melissamn / Shutterstock

The secular trend of on-demand video streaming has created several winners in the tech space. Over the past five years, Roku’s stock has increased in value by more than 700%.

The platform provides access to streaming services such as Youtube, Netflix and Disney+. Roku also offers its own ad-supported channels featuring licensed third-party content.

The company added 1.3 million active accounts in Q3. Total revenue rose 51% year-over-year to $680 million.

Naturally, there are larger ways to play these massive streaming tailwinds. Netflix just added 4.4 million new subscribers in Q3, while the worldwide subscriber count at Disney+ stands at a whopping 118.1 million.

But Wood is clearly most bullish on Roku — unlike Disney, it’s a “pure” way to play the trend — with the shares representing 5.1% of ARKK’s weight.

While commercial real estate to has always been reserved for a few elite investors, outperforming the S&P 500 over a 25-year period, First National Realty Partners allows you to access institutional-quality commercial real estate investments — without the leg work of finding deals yourself.

Get started

Big potential without the whiplash

Andy Warhol gallery
dmitro2009 / Shutterstock

The fund’s focus on disruptive innovation has served Wood well, but the most exciting tickers can also be the most volatile.

Remember, stocks aren’t the only asset class that has shot through the roof over the years.

If you want to invest in something more stable that still has high return potential, consider this overlooked option: fine art.

Contemporary artwork has outperformed the S&P 500 by a commanding 174% over the past 25 years, according to the Citi Global Art Market chart.

Investing in art by the likes of Banksy and Andy Warhol used to be an option only for the ultra rich, like Wood. But with a new investing platform, you can invest in iconic artworks, too, just like Jeff Bezos and Bill Gates do.

Fine art as an investment

Stocks can be volatile, cryptos make big swings to either side, and even gold is not immune to the market’s ups and downs.

That’s why if you are looking for the ultimate hedge, it could be worthwhile to check out a real, but overlooked asset: fine art.

Contemporary artwork has outperformed the S&P 500 by a commanding 174% over the past 25 years, according to the Citi Global Art Market chart.

And it’s becoming a popular way to diversify because it’s a real physical asset with little correlation to the stock market.

On a scale of -1 to +1, with 0 representing no link at all, Citi found the correlation between contemporary art and the S&P 500 was just 0.12 during the past 25 years.

Earlier this year, Bank of America investment chief Michael Harnett singled out artwork as a sharp way to outperform over the next decade — due largely to the asset’s track record as an inflation hedge.

Investing in art by the likes of Banksy and Andy Warhol used to be an option only for the ultrarich. But with a new investing platform, you can invest in iconic artworks just like Jeff Bezos and Bill Gates do.

About the Author

Jing Pan

Jing Pan

Investment Reporter

Jing is an investment reporter for MoneyWise. Prior to joining the team, he was a research analyst and editor at one of the leading financial publishing companies in North America. An avid advocate of investing for passive income, he wrote a monthly dividend stock newsletter for the better half of the past decade. Jing holds a Master’s Degree in Economics and an Honours Bachelor of Science Degree, both from the University of Toronto.

What to Read Next


The content provided on MoneyWise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.